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the study (1,210 in the intervention group and 794 in the control group). Some female clients also participated though not all data items were collected for this group. All clients who attended the clinic during the study period were asked to participate in the study, and 99% agreed to do so. Thus, the sample would appear to have been appropriate for the study question. No power calculations are reported.
Study design
This was a single-centre randomised clinical trial. Participants were followed-up for an average of 17 months to determine the incidence of new STDs. The completion rate was 97%. The authors did not comment on those clients who did not complete the study. Additional information about the study design can be found in the first reference listed later (see "Other Publications of Related Interest").
Analysis of effectiveness
The authors did not report whether the analysis was performed on the basis of intention to treat or treatment completers only. The article provided no details of the baseline comparability of the two groups. The primary health outcomes were the number and frequency of sexual contacts and incident STDs, defined as an STD diagnosed at least 30 days after the intervention. These data were obtained for each participant through the New York City STD surveillance system.
Effectiveness results
Applying the results of the effectiveness study within the model (and including parameters values assessed in the literature review), it was estimated that 94.8% of the intervention group used condoms as compared with 86.2% in the control group. 
Clinical conclusions
This video-based intervention is one of the few interventions shown to be effective in male, heterosexual, non-injectingdrug-using populations in reducing the incidence of STDs.
Modelling
A previously published equation of HIV transmission dynamics was used to deduce the impact of the intervention on condom use via the observed impact on incident STDs. This was in turn used to estimate the number of HIV infections averted by the intervention. Probability distributions were assigned to some of the model parameters and probabilistic models were used to relate costs to two outcome measures (HIV infections averted and QALYs gained).
Outcomes assessed in the review
The outcomes assessed by a review were the prevalence of STDs and HIV in the study population, the effectiveness of condoms, and the transmissibility of HIV and STDs.
Criteria used to ensure the validity of primary studies
Not stated.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Four primary studies were included.
Methods of combining primary studies
Investigation of differences between primary studies
Not reported.
Results of the review
The prevalence of HIV was 5% and the prevalence of STDs was 0.23 (range: 0.172 -0.30).
The transmission probabilities for HIV and STDs in a single sexual contact were 0.0056 (95% CI: 0.0041 -0.0075) and 0.150 (95% CI: 0.10 -0.253), respectively.
Methods used to derive estimates of effectiveness
The authors make some assumptions in using their models.
Estimates of effectiveness and key assumptions
The prevalence of HIV among partners of non-HIV-infected participants was assumed to be equal to the overall prevalence of 5%.
Partners of HIV-positive participants were assumed to have a higher prevalence of 7%.
It was estimated that condoms were 90% effective.
Measure of benefits used in the economic analysis
The primary outcome measure was HIV infections averted. This benefit measure was translated to quality-adjusted life years (QALYs) gained using quality of life weights related to four stages of HIV/AIDS.
Direct costs
Direct costs included in the analysis were start-up costs (including the videos, other equipment and staff training), recurrent costs (primarily labour costs) and client-specific costs (including materials provided to each participant). The resource use quantities were obtained from a detailed study of four centres offering the intervention, though it was not clear when this was carried out or if the unit costs were also obtained from this source. Some resource use quantities were reported separately or can be deduced from the information presented. Capital expenditures (such as the purchase of the TV or VCR) were annuitised and distributed across the life of the project with a 5% discount rate being used in the annuity function. In the cost-utility analysis, the authors used HIV treatment costs derived from one particular study and inflated to 1999 dollars. A discount rate of 5% was used for costs (and outcomes). The authors stated that no
